Skip to main content
TB

Trait Biosciences

Trait Biosciences Inc. develops proprietary water-soluble cannabinoid technology that enhances cannabinoid production and ensures zero THC in hemp, addressing the limitations of traditional oil-based products. Their solutions enable clear, high-dosage formulations suitable for diverse applications in food, beverages, beauty aids, and supplements.

Santa Fe, ArgentinaFounded 2017202K+ followers
Updated 20 months ago

Funding

$46.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

BVGG
Funding rounds are not available yet.

Founders

Product

Problem

Traditional cannabinoid products are oil-based, which limits their bioavailability and applicability in various consumer products. These oil-based formulations often result in poor absorption, inconsistent effects, and challenges in creating clear, high-dosage products.

Solution

Trait Biosciences has developed a suite of proprietary technology platforms focused on water-soluble cannabinoids, offering an alternative to traditional oil-based products. Their technology enhances cannabinoid production and enables the creation of clear, high-dosage formulations suitable for diverse applications, including food, beverages, beauty aids, supplements, and pet goods. Trait's water-soluble cannabinoids overcome the limitations of oil-based products, providing improved bioavailability and versatility in product development.

Target Audience

Trait Biosciences targets companies in the food and beverage, beauty aids, supplements, and pet goods industries seeking to incorporate cannabinoids into their products with improved bioavailability and clarity.

Features

  • "Truly" water-soluble cannabinoid extracts, eliminating the need for nano-emulsification or encapsulation.
  • Clear and colorless formulations, maintaining the aesthetic appeal of infused products.
  • Increased dosage capacity while maintaining clarity.
  • Proprietary technology platforms for enhanced cannabinoid production.
  • State-of-the-art laboratory equipped for microbiology, genetics, biochemistry, chemistry, and advanced analytical testing.
  • Capabilities in fermentation, metabolic engineering, bioinformatics, computational biology, and plant secondary metabolism.
This profile is AI-generated and may contain inaccuracies.